North America Clinical Nutrition Market Size (2024 - 2029)

North America Medical Clinical Nutrition Market Analysis

The North America Clinical Nutrition Market size is estimated at USD 29.88 billion in 2024, and is expected to reach USD 40.35 billion by 2029, growing at a CAGR of 6.19% during the forecast period (2024-2029).

COVID-19 has significantly impacted the growth of the clinical nutrition market in North America. The increasing risks associated with COVID-19 led to more consumption of clinical nutrition. The research studies conducted to demonstrate the effectiveness of clinical nutrition are also expected to drive the growth of the market studied. For instance, the article 'The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit' published in July 2020, suggested that proper evidence-based nutritional therapy was reported for patients with critical COVID-19 conditions and recommended to be included in life-saving therapies. Thus, COVID-19 has impacted market growth during the pandemic.

Certain factors that are propelling the market growth are the increasing prevalence of metabolic disorders, rising spending on healthcare by government and private foundations, and the rising aging population in North American countries.

The growing burden of metabolic disorders is the key factor driving the market growth. For instance, according to statistics published by the International Diabetes Federation, in the 10th edition of 2021, 2,974.0 thousand people were living with diabetes in 2021 in Canada. In addition, as per the same source, this number is projected to reach 3,288.2 thousand by 2030 and 3,468.5 thousand by 2045. Therefore, high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to a variety of cardiovascular diseases like coronary artery disease and stroke. This is expected to increase the demand for clinical nutrition to maintain their glucose level, thereby bolstering the market growth.

Additionally, obesity in the Mexican population is found to be the most prevalent heart disease risk factor which is also contributing to the growth of the studied market over the forecast period. For instance, according to 2022 statistics published by World Obesity Federation, it has been observed that 31.5% of men and 40.2% of women are living with obesity in Mexico in 2020. Thus, the growing cases of metabolic disorders among the population in the region are contributing to the market growth over the forecast period.

Furthermore, the growing geriatric population is more prone to develop metabolic disorders due to multiple age-related physiologic mechanisms which are expected to increase the demand for clinical nutrition, thereby propelling the market growth. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Canada, a large proportion of the living population is aged 15-64 and accounts for 65% in 2022. In addition, as per the same source, 19% of the population is aged 65 years and above in 2022. This is expected to boost market growth over the forecast period. The geriatric population shows more vulnerability to diseases that require clinical nutrition, thereby propelling market growth over the forecast period.

However, the imprecise perception of clinical nutrition and the reduction in birth rates are some of the factors that are restraining the market growth over the forecast period.

North America Medical Clinical Nutrition Industry Segmentation

As per the scope of the report, clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. A higher number of premature births also demand advanced clinical nutrition. The North America Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral, Parenteral), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Neurological Diseases, Cancer, Other Indications), End-User (Pediatric and Adult), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.